Cheviot Value Management’s Core Laboratories CLB Stock Holding History

Cheviot Value Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47	Hold	4	–	–	﹤0.01%	434
2026 Q1	$67	Hold	4	–	–	﹤0.01%	413
2025 Q4	$75	Hold	4	–	–	﹤0.01%	405
2025 Q3	$66	Hold	4	–	–	﹤0.01%	435
2025 Q2	$41	Hold	4	–	–	﹤0.01%	426
2025 Q1	$48	Buy	+4	New	+$67	﹤0.01%	447

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cheviot Value Management's CLB Position: Q2 2026 in Review

Cheviot Value Management held its Core Laboratories (CLB) position steady in Q2 2026 at 4 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Cheviot Value Management first reported a position in CLB in Q1 2025 and has held it in 6 quarters since. The position peaked at $75 in Q4 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Cheviot Value Management held 4 shares of Core Laboratories worth $47 as of Q2 2026.
Cheviot Value Management left its Core Laboratories share count unchanged in Q2 2026.
Core Laboratories made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #434 holding.
Cheviot Value Management first reported a position in Core Laboratories in Q1 2025 and has held it in 6 quarters since.
Cheviot Value Management's Core Laboratories position peaked at $75 in Q4 2025.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.